MSD Partners’s Precigen PGEN Stock Holding History

MSD Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-355,000	Closed	-$336K	–	15
2024 Q3	$336K	Hold	355,000	–	–	0.21%	11
2024 Q2	$561K	Hold	355,000	–	–	0.05%	13
2024 Q1	$515K	Hold	355,000	–	–	0.04%	14
2023 Q4	$476K	Sell	355,000 -605,000	-63%	-$711K	0.04%	15
2023 Q3	$1.36M	Hold	960,000	–	–	0.11%	28
2023 Q2	$1.1M	Hold	960,000	–	–	0.1%	30
2023 Q1	$1.02M	Hold	960,000	–	–	0.08%	34
2022 Q4	$1.46M	Hold	960,000	–	–	0.14%	33
2022 Q3	$2.04M	Hold	960,000	–	–	0.16%	36
2022 Q2	$1.29M	Hold	960,000	–	–	0.08%	50
2022 Q1	$2.03M	Sell	960,000 -1,920,000	-67%	-$4.67M	0.11%	48
2021 Q4	$10.7M	Buy	2,880,000 +1,920,000	+200%	+$8.26M	0.12%	53
2021 Q3	$4.79M	Hold	960,000	–	–	0.15%	41
2021 Q2	$6.26M	Hold	960,000	–	–	0.16%	39
2021 Q1	$6.61M	Buy	960,000 +350,000	+57%	+$2.96M	0.25%	37
2020 Q4	$6.22M	Hold	610,000	–	–	1.04%	19
2020 Q3	$2.13M	Hold	610,000	–	–	0.45%	24
2020 Q2	$3.04M	Hold	610,000	–	–	0.78%	17
2020 Q1	$2.07M	Sell	610,000 -290,000	-32%	-$1.25M	0.56%	19
2019 Q4	$4.93M	Sell	900,000 -100,000	-10%	-$563K	1.09%	12
2019 Q3	$5.72M	Hold	1,000,000	–	–	0.77%	15
2019 Q2	$7.66M	Hold	1,000,000	–	–	0.93%	19
2019 Q1	$5.26M	Buy	+1,000,000	New	+$6.93M	0.65%	21
2018 Q3	–	Sell	-400,000	Closed	-$5.58M	–	43
2018 Q2	$5.58M	Hold	400,000	–	–	0.24%	26
2018 Q1	$6.13M	Buy	+400,000	New	+$5.72M	0.31%	21

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MSD Partners's PGEN Position: Q4 2024 in Review

MSD Partners sold out of Precigen (PGEN) in Q4 2024, closing a stake of 355,000 shares — an estimated $336K sold.

MSD Partners first reported a position in PGEN in Q1 2018 and held it in 25 quarters. The position peaked at $10.7M in Q4 2021. 133 funds tracked by Wall St. Rank hold PGEN as of Q4 2024.

MSD Partners reported no remaining Precigen position as of Q4 2024 after selling out during the quarter.
MSD Partners sold 355,000 Precigen shares in Q4 2024, an estimated $336K.
MSD Partners first reported a position in Precigen in Q1 2018 and held it in 25 quarters.
MSD Partners's Precigen position peaked at $10.7M in Q4 2021.
133 funds tracked by Wall St. Rank held Precigen as of Q4 2024.

Based on MSD Partners's 13F filing for Q4 2024, filed 14 Feb 2025.